372
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells

, , , , , & show all
Pages 2432-2436 | Received 17 Aug 2015, Accepted 31 Dec 2015, Published online: 17 Feb 2016
 

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2016.1138292.

Funding information

This work was funded by the Leukemia and Lymphoma Society of Canada, the Canadian Stem Cell Network, the Canadian Institutes of Health Research (CIHR), the Princess Margaret Cancer Centre Foundation, and the Ministry of Long Term Health and Planning in the Province of Ontario. LER was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship, CIHR MD/PhD Studentship, Peterborough KM Hunter Graduate Studentship, and Hernandez Family Oncology MD/PhD Fellowship. ADS holds the Baker Chair in Leukemia and Related Diseases.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.